O-acetyl-serine, a metabolite from gut microbes and plants, enhances glucose-dependent insulin secretion and improves blood sugar control in lean and prediabetic mice.
Glucose-dependent actionOAS only boosts insulin when blood sugar is elevated, reducing hypoglycemia risk
What the researchers found
OAS acts as a glucose-dependent insulin secretagogue, accumulating in the pancreas after oral administration and dose-dependently improving postprandial glycemia in lean and prediabetic mice.
Why it matters
A natural, glucose-dependent insulin secretagogue from gut microbes could offer a safer approach to prediabetes intervention than existing drugs, with lower hypoglycemia risk.
How the study worked
Preclinical study developing a targeted OAS quantification method and testing oral OAS supplementation in lean and prediabetic mouse models, measuring plasma/tissue levels, insulin secretion, and glycemic outcomes.
What this study cannot tell us
Mouse study only — human metabolism and response may differ significantly. Long-term safety and efficacy not assessed. OAS bioavailability in humans unknown.
How to read the evidence
Preclinical animal study with novel metabolite — demonstrates proof of concept but requires human validation.
When this study was published
Published in 2026; represents a new area of microbiome-metabolite diabetes research.
The bigger picture
This connects the gut microbiome to blood sugar regulation in a concrete, actionable way — suggesting that what our gut bacteria produce directly influences diabetes risk.
Questions still open
- Would OAS supplementation work in humans with prediabetes?
- Could probiotics that produce more OAS be an alternative to direct supplementation?
Common questions
What is O-acetyl-serine?
Could this help prevent type 2 diabetes?
Read the original research
O-Acetyl-Serine Supplementation Enhances Insulin Secretion and Improves Postprandial Glycaemia in Lean and Prediabetic Mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(4), e71543
Citation
Benatar, Clara; Zhang, Xufei; Haddam, Ines; Ribes, Sandy; Bobet, Sophie; Monnoye, Magali; Lamy, Elodie; Grassin-Delyle, Stanislas; Juillard, Vincent; Layec, Séverine; Delorme, Christine; Douard, Véronique. (2026). O-Acetyl-Serine Supplementation Enhances Insulin Secretion and Improves Postprandial Glycaemia in Lean and Prediabetic Mice.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(4), e71543. https://doi.org/10.1096/fj.202502925R